Caricamento...

Hydroxyurea and Zileuton Differentially Modulate Cell Proliferation and Interleukin-2 Secretion by Murine Spleen Cells: Possible Implication on the Immune Function and Risk of Pain Crisis in Patients with Sickle Cell Disease

BACKGROUND: Hydroxyurea (HU) reduces major complications associated with sickle cell disease in part because of the induction of fetal hemoglobin. However, because of its antiproliferative property, its long-term use may impair immunity. Zileuton, a derivative of HU, also induces fetal hemoglobin an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ochsner J
Autori principali: Kuvibidila, Solo, Warrier, Rajasekharan P., Haynes, Johnson, Baliga, Surendra B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: the Academic Division of Ochsner Clinic Foundation 2015
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4569155/
https://ncbi.nlm.nih.gov/pubmed/26412995
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !